# TFAM

## Overview
The TFAM gene encodes the mitochondrial transcription factor A, a pivotal protein involved in the regulation and maintenance of mitochondrial DNA (mtDNA). As a member of the high-mobility group (HMG) box family, TFAM is characterized by its ability to bind and bend DNA, facilitating the transcription and replication of mtDNA. This protein plays a crucial role in the organization of mtDNA into nucleoprotein complexes known as nucleoids, which are essential for maintaining mitochondrial genome integrity and function (Pohjoismäki2006Alterations; Cuppari2019DNA). TFAM's interactions with other mitochondrial transcription factors and its involvement in DNA repair processes underscore its multifaceted role in mitochondrial biology (Xu2022DNA–protein; Kozhukhar202335). Dysregulation of TFAM expression or function is implicated in various pathological conditions, including cancer, neurodegenerative diseases, and metabolic disorders, highlighting its significance in cellular homeostasis and disease (Kang2018The; Longo2023Altered).

## Structure
The human transcription factor A, mitochondrial (TFAM), is a protein characterized by its two high-mobility group (HMG) box domains, HMG-box1 and HMG-box2, which are connected by a linker region (Cuppari2019DNA). These domains are crucial for TFAM's ability to bind and bend DNA, inducing a U-turn in the DNA structure (Ngo2014Distinct). The HMG-box domains intercalate into the minor groove of DNA, with specific leucine residues facilitating the bending by disrupting stacking interactions (Cuppari2019DNA). 

TFAM's tertiary structure allows it to wrap around DNA, stabilizing it and facilitating the formation of higher-order structures called nucleoids (Hillen2018Structural). The protein can dimerize, which is essential for DNA compaction, although not necessary for DNA bending or transcriptional activation (Ngo2014Distinct). This dimerization is mediated through interactions between the HMG-box domains, forming DNA loops that contribute to mitochondrial DNA organization (Ngo2014Distinct).

TFAM also contains a C-terminal tail, which is important for transcriptional activation, particularly at the light strand promoter (LSP) (Ngo2014Distinct). The protein's structure and function are influenced by its concentration within mitochondria, with higher concentrations leading to DNA compaction (Cuppari2019DNA).

## Function
The human gene TFAM (transcription factor A, mitochondrial) encodes a protein that plays a critical role in the maintenance and expression of mitochondrial DNA (mtDNA) in healthy human cells. TFAM is essential for the transcription and replication of mtDNA, acting as a core component of the mitochondrial transcription machinery. It binds sequence-specifically to sites upstream of mitochondrial promoters, facilitating the recruitment of the transcription machinery, including the human mitochondrial RNA polymerase (POLRMT) and TFB2M, to initiate transcription (Shi2012Mammalian).

TFAM also functions as a DNA packaging factor, compacting mtDNA into nucleoprotein complexes known as nucleoids. This compaction is crucial for the structural maintenance of mtDNA, similar to the role of histones in the nucleus (Pohjoismäki2006Alterations; Kaufman2007The). The protein's ability to bind and bend DNA facilitates the organization of mitochondrial chromatin and influences mtDNA replication and copy number (Pohjoismäki2006Alterations; Brown2015Mitochondrial).

TFAM's expression levels are tightly regulated, as both overexpression and depletion can lead to alterations in mtDNA copy number and transcriptional activity, impacting cellular energy production and mitochondrial function (Pohjoismäki2006Alterations; Picca2015Regulation).

## Clinical Significance
Alterations in the expression or function of the TFAM gene are linked to several diseases and conditions. In cancer, TFAM is often upregulated, contributing to carcinogenesis, cell proliferation, and resistance to apoptosis. For instance, in gastric cancer, TFAM depletion leads to mitochondrial dysfunction and altered cell morphology, affecting tumor cell differentiation and proliferation (Lee2017Transcriptomic). In colorectal cancer with microsatellite instability, TFAM truncating mutations result in reduced protein levels, promoting tumor growth and resistance to chemotherapy (Guo2011Frequent).

In neurodegenerative diseases, TFAM levels are typically reduced, correlating with decreased mitochondrial DNA (mtDNA) copy number and impaired mitochondrial function. This reduction is observed in conditions such as Parkinson's, Alzheimer's, and Huntington's diseases, where it is associated with mitochondrial dysfunction and neurodegeneration (Kang2018The).

In metabolic disorders, particularly in individuals predisposed to type 2 diabetes, reduced TFAM expression is linked to impaired adipocyte differentiation and mitochondrial dysfunction. This is due to epigenetic changes at the TFAM promoter, leading to decreased mtDNA content and contributing to insulin resistance and adipose tissue dysfunction (Longo2023Altered).

## Interactions
Mitochondrial transcription factor A (TFAM) is involved in various interactions with nucleic acids and proteins, playing a crucial role in mitochondrial DNA (mtDNA) maintenance and transcription. TFAM binds with high affinity to the mitochondrial light-strand promoter (LSP) double-stranded DNA (dsDNA), with an apparent dissociation constant (K_d) of 6 nM, indicating strong binding interactions (Brown2015Mitochondrial). It also interacts with complex RNA structures, such as RNA internal loops and 4-way junctions, although with varying affinities. For instance, TFAM binds to RNA-only 4-way junctions with a K_d of 270 nM and to RNA:DNA hybrid 4-way junctions with a K_d of ~299 nM (Brown2015Mitochondrial).

TFAM's interactions extend to proteins involved in mitochondrial transcription. It interacts with mitochondrial transcription factors such as TFB2M, which is essential for promoter melting and transcription initiation (Kozhukhar202335). TFAM also binds to mature mitochondrial tRNAs, suggesting a role in RNA processing and translation (Brown2015Mitochondrial). Additionally, TFAM is involved in the formation of DNA-protein cross-links with abasic DNA lesions, indicating its role in mtDNA repair and maintenance (Xu2022DNA–protein). These interactions highlight TFAM's multifaceted role in mitochondrial function.


## References


[1. (Xu2022DNA–protein) Wenyan Xu, Jin Tang, and Linlin Zhao. Dna–protein cross-links between abasic dna damage and mitochondrial transcription factor a (tfam). Nucleic Acids Research, 51(1):41–53, December 2022. URL: http://dx.doi.org/10.1093/nar/gkac1214, doi:10.1093/nar/gkac1214. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkac1214)

[2. (Shi2012Mammalian) Yonghong Shi, Anke Dierckx, Paulina H. Wanrooij, Sjoerd Wanrooij, Nils-Göran Larsson, L. Marcus Wilhelmsson, Maria Falkenberg, and Claes M. Gustafsson. Mammalian transcription factor a is a core component of the mitochondrial transcription machinery. Proceedings of the National Academy of Sciences, 109(41):16510–16515, September 2012. URL: http://dx.doi.org/10.1073/pnas.1119738109, doi:10.1073/pnas.1119738109. This article has 157 citations.](https://doi.org/10.1073/pnas.1119738109)

[3. (Brown2015Mitochondrial) Timothy A. Brown, Ariana N. Tkachuk, and David A. Clayton. Mitochondrial transcription factor a (tfam) binds to rna containing 4-way junctions and mitochondrial trna. PLOS ONE, 10(11):e0142436, November 2015. URL: http://dx.doi.org/10.1371/journal.pone.0142436, doi:10.1371/journal.pone.0142436. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0142436)

[4. (Ngo2014Distinct) H.B. Ngo, G.A. Lovely, R. Phillips, and D.C. Chan. Distinct structural features of tfam drive mitochondrial dna packaging versus transcriptional activation. January 2014. URL: http://dx.doi.org/10.2210/pdb4nnu/pdb, doi:10.2210/pdb4nnu/pdb. This article has 0 citations.](https://doi.org/10.2210/pdb4nnu/pdb)

[5. (Pohjoismäki2006Alterations) Jaakko L. O. Pohjoismäki, Sjoerd Wanrooij, Anne K. Hyvärinen, Steffi Goffart, Ian J. Holt, Johannes N. Spelbrink, and Howard T. Jacobs. Alterations to the expression level of mitochondrial transcription factor a, tfam, modify the mode of mitochondrial dna replication in cultured human cells. Nucleic Acids Research, 34(20):5815–5828, November 2006. URL: http://dx.doi.org/10.1093/nar/gkl703, doi:10.1093/nar/gkl703. This article has 138 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkl703)

[6. (Hillen2018Structural) Hauke S. Hillen, Dmitry Temiakov, and Patrick Cramer. Structural basis of mitochondrial transcription. Nature Structural &amp; Molecular Biology, 25(9):754–765, September 2018. URL: http://dx.doi.org/10.1038/s41594-018-0122-9, doi:10.1038/s41594-018-0122-9. This article has 69 citations.](https://doi.org/10.1038/s41594-018-0122-9)

[7. (Picca2015Regulation) Anna Picca and Angela Maria Serena Lezza. Regulation of mitochondrial biogenesis through tfam–mitochondrial dna interactions. Mitochondrion, 25:67–75, November 2015. URL: http://dx.doi.org/10.1016/j.mito.2015.10.001, doi:10.1016/j.mito.2015.10.001. This article has 214 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mito.2015.10.001)

[8. (Lee2017Transcriptomic) Woo Rin Lee, Heeju Na, Seon Woo Lee, Won-Jun Lim, Namshin Kim, J. Eugene Lee, and Changwon Kang. Transcriptomic analysis of mitochondrial tfam depletion changing cell morphology and proliferation. Scientific Reports, December 2017. URL: http://dx.doi.org/10.1038/s41598-017-18064-9, doi:10.1038/s41598-017-18064-9. This article has 30 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-18064-9)

[9. (Guo2011Frequent) Jianhui Guo, Li Zheng, Wenyong Liu, Xianshu Wang, Zemin Wang, Zehua Wang, Amy J. French, Dongchon Kang, Lin Chen, Stephen N. Thibodeau, and Wanguo Liu. Frequent truncating mutation of tfam induces mitochondrial dna depletion and apoptotic resistance in microsatellite-unstable colorectal cancer. Cancer Research, 71(8):2978–2987, April 2011. URL: http://dx.doi.org/10.1158/0008-5472.can-10-3482, doi:10.1158/0008-5472.can-10-3482. This article has 85 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-10-3482)

[10. (Kaufman2007The) Brett A. Kaufman, Nela Durisic, Jeffrey M. Mativetsky, Santiago Costantino, Mark A. Hancock, Peter Grutter, and Eric A. Shoubridge. The mitochondrial transcription factor tfam coordinates the assembly of multiple dna molecules into nucleoid-like structures. Molecular Biology of the Cell, 18(9):3225–3236, September 2007. URL: http://dx.doi.org/10.1091/mbc.e07-05-0404, doi:10.1091/mbc.e07-05-0404. This article has 324 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e07-05-0404)

[11. (Kozhukhar202335) Natalya Kozhukhar and Mikhail F. Alexeyev. 35 years of tfam research: old protein, new puzzles. Biology, 12(6):823, June 2023. URL: http://dx.doi.org/10.3390/biology12060823, doi:10.3390/biology12060823. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biology12060823)

[12. (Kang2018The) Inhae Kang, Charleen T. Chu, and Brett A. Kaufman. The mitochondrial transcription factor <scp>tfam</scp> in neurodegeneration: emerging evidence and mechanisms. FEBS Letters, 592(5):793–811, February 2018. URL: http://dx.doi.org/10.1002/1873-3468.12989, doi:10.1002/1873-3468.12989. This article has 198 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/1873-3468.12989)

[13. (Cuppari2019DNA) Anna Cuppari, Pablo Fernández-Millán, Federica Battistini, Aleix Tarrés-Solé, Sébastien Lyonnais, Guillermo Iruela, Elena Ruiz-López, Yuliana Enciso, Anna Rubio-Cosials, Rafel Prohens, Miquel Pons, Carlos Alfonso, Katalin Tóth, Germán Rivas, Modesto Orozco, and Maria Solà. Dna specificities modulate the binding of human transcription factor a to mitochondrial dna control region. Nucleic Acids Research, 47(12):6519–6537, May 2019. URL: http://dx.doi.org/10.1093/nar/gkz406, doi:10.1093/nar/gkz406. This article has 20 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkz406)

[14. (Longo2023Altered) Michele Longo, Federica Zatterale, Rosa Spinelli, Jamal Naderi, Luca Parrillo, Pasqualina Florese, Cecilia Nigro, Alessia Leone, Augusta Moccia, Antonella Desiderio, Gregory A. Raciti, Claudia Miele, Ulf Smith, and Francesco Beguinot. Altered h3k4me3 profile at the tfam promoter causes mitochondrial alterations in preadipocytes from first-degree relatives of type 2 diabetics. Clinical Epigenetics, September 2023. URL: http://dx.doi.org/10.1186/s13148-023-01556-z, doi:10.1186/s13148-023-01556-z. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13148-023-01556-z)